Blog

Oct 28, 2024, 10:54

SPCC – Brian Druker reflects on the key milestones of his life and career

SPCC (Sharing Progress in Cancer Care) shared on Linkedin:

”Have you already watched Aleksandra Filipovic’s inspirational interview with Brian Druker, the esteemed director of the OHSU Knight Cancer Institute?

Known for his groundbreaking work in cancer research, Druker developed Gleevec, a targeted therapy that revolutionised the treatment of chronic myeloid leukemia (CML) by attacking cancer cells while preserving healthy ones.

In the interview, Druker reflects on the key milestones of his life and career, from his early days to his present work.

Every new drug has a human who has championed it to existence, who persevered, who believed. Who knew the ‘Why’ and therefore found the ‘How’.

Watch it now.”

Aleksandra Filipovic Brian Druker cancer Cancer research Chronic myeloid leukemia (CML) CML OHSU Knight Cancer Institute OncoDaily Oncology SPCC (Sharing Progress in Cancer Care)

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage